Symbyax and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Symbyax (fluoxetine hydrochloride; olanzapine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Seroquel, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Symbyax. It is created by eHealthMe based on reports of 1,347 people who have side effects when taking Symbyax from the FDA, and is updated regularly.

What is Symbyax?

Symbyax has active ingredients of fluoxetine hydrochloride; olanzapine. It is often used in depression. eHealthMe is studying from 1,449 Symbyax users. Check the latest studies of Symbyax.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,643 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

On Jul, 23, 2026

1,347 people reported to have side effects when taking Symbyax.
Among them, 17 people (1.26%) have Type 1 diabetes.

Among these 17 people:

How long have people been on Symbyax when they have Type 1 diabetes? *

What is the gender of people who have Type 1 diabetes when taking Symbyax? *

female: 64.71 %
male: 35.29 %

What is the age of people who have Type 1 diabetes when taking Symbyax? *

What are other drugs people take besides Symbyax? *

What are other side effects people have besides Type 1 diabetes? *

Type 2 Diabetes: 11 people, 64.71%
High Blood Cholesterol: 8 people, 47.06%
Neuropathy Peripheral (surface nerve damage): 5 people, 29.41%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 5 people, 29.41%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 29.41%
Hypoglycemia (low blood sugar): 5 people, 29.41%
Pancreatitis (inflammation of pancreas): 4 people, 23.53%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 23.53%
Diabetes: 4 people, 23.53%
Hyperglycemia (high blood sugar): 4 people, 23.53%

What are the existing conditions these people have? *

Stress And Anxiety: 5 people, 29.41%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 17.65%
Insomnia (sleeplessness): 3 people, 17.65%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 11.76%
Sleep Disorder: 1 person, 5.88%
Psychotic Disorder: 1 person, 5.88%
Post-Traumatic Stress Disorder: 1 person, 5.88%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.88%
Dizziness: 1 person, 5.88%
Diabetes: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Symbyax and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Symbyax:

Symbyax (1,449 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,845 reports)

How severe was Type 1 diabetes and when was it recovered:

Type 1 diabetes in Symbyax

Expand to all the drugs that have ingredients of fluoxetine hydrochloride; olanzapine:

Type 1 diabetes and drugs with ingredients of fluoxetine hydrochloride; olanzapine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Symbyax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (668 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,643 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluoxetine hydrochloride; olanzapine (the active ingredients of Symbyax) and Symbyax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.